OrthoPediatrics (FRA:2X7) Cyclically Adjusted FCF per Share: €-1.57 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2X7 OrthoPediatrics Corp FRA:2X7
77 GF Score
Price €17.70
GF Value €31.63
! 5 Warning Signs
View Full Analysis

What is OrthoPediatrics Cyclically Adjusted FCF per Share?

OrthoPediatrics FRA:2X7 +9.94% 77 Cyclically Adjusted FCF per Share is €-1.57 as of Mar. 2026. GuruFocus rates FRA:2X7 with a GF Score™ of 77/100 and a GF Value™ of €31.63. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

OrthoPediatrics's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.184. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-1.57 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-18), OrthoPediatrics's current stock price is €17.70. OrthoPediatrics's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-1.57. OrthoPediatrics's Cyclically Adjusted Price-to-FCF of today is .


OrthoPediatrics  (FRA:2X7) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


OrthoPediatrics Cyclically Adjusted FCF per Share Related Terms


OrthoPediatrics Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for OrthoPediatrics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OrthoPediatrics Cyclically Adjusted FCF per Share Chart

OrthoPediatrics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -1.58

OrthoPediatrics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.82 -1.68 -1.67 -1.58 -1.57

FRA:2X7 vs PACB, CLPT, MOBI: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, OrthoPediatrics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrthoPediatrics Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrthoPediatrics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where OrthoPediatrics's Cyclically Adjusted Price-to-FCF falls into.


FRA:2X7
77GF Score
OrthoPediatrics Corp FRA:2X7
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OrthoPediatrics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, OrthoPediatrics's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.184/330.2130*330.2130
=-0.184

Current CPI (Mar. 2026) = 330.2130.

OrthoPediatrics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.206 241.018 -0.282
201609 -0.161 241.428 -0.220
201612 -0.052 241.432 -0.071
201703 -0.878 243.801 -1.189
201706 -0.680 244.955 -0.917
201709 -0.126 246.819 -0.169
201712 -0.307 246.524 -0.411
201803 -0.535 249.554 -0.708
201806 -0.550 251.989 -0.721
201809 -0.159 252.439 -0.208
201812 -0.181 251.233 -0.238
201903 -0.521 254.202 -0.677
201906 -0.652 256.143 -0.841
201909 -0.152 256.759 -0.195
201912 -0.497 256.974 -0.639
202003 -0.601 258.115 -0.769
202006 -0.494 257.797 -0.633
202009 -0.220 260.280 -0.279
202012 -0.181 260.474 -0.229
202103 -0.329 264.877 -0.410
202106 -0.461 271.696 -0.560
202109 -0.352 274.310 -0.424
202112 -0.132 278.802 -0.156
202203 -0.394 287.504 -0.453
202206 -0.642 296.311 -0.715
202209 -0.339 296.808 -0.377
202212 -0.127 296.797 -0.141
202303 -0.473 301.836 -0.517
202306 -0.406 305.109 -0.439
202309 -0.459 307.789 -0.492
202312 -0.458 306.746 -0.493
202403 -0.530 312.332 -0.560
202406 -0.513 314.175 -0.539
202409 -0.453 315.301 -0.474
202412 -0.154 315.605 -0.161
202503 -0.334 319.799 -0.345
202506 -0.514 322.561 -0.526
202509 -0.124 324.800 -0.126
202512 0.353 324.054 0.360
202603 -0.184 330.213 -0.184

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-1.57 mean?
OrthoPediatrics (FRA:2X7) has a Cyclically Adjusted FCF per Share of €-1.57 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on OrthoPediatrics and its competitors.
Is OrthoPediatrics' Cyclically Adjusted FCF per Share too high?
OrthoPediatrics' current Cyclically Adjusted FCF per Share is €-1.57. Overall, OrthoPediatrics has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does OrthoPediatrics' Cyclically Adjusted FCF per Share compare to PACB and CLPT?
OrthoPediatrics' Cyclically Adjusted FCF per Share of €-1.57 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on OrthoPediatrics and its competitors. OrthoPediatrics's current Cyclically Adjusted FCF per Share is €-1.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrthoPediatrics stock overvalued right now?
OrthoPediatrics (FRA:2X7) has a current Cyclically Adjusted FCF per Share of €-1.57. The stock's GF Value™ is €31.63, compared to a current price of €17.70 — trading 44% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €-1.57. OrthoPediatrics' overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For OrthoPediatrics (FRA:2X7), the current Cyclically Adjusted FCF per Share is €-1.57 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OrthoPediatrics (FRA:2X7) Overvalued in 2026?

Based on GuruFocus' analysis, OrthoPediatrics stock appears to be undervalued. The current stock price of €17.70 is trading 44% below its estimated GF Value™ of €31.63.

Key valuation signals for FRA:2X7:

  • Cyclically Adjusted FCF per Share: €-1.57
  • GF Value™: €31.63 vs. price of €17.70 (44% below fair value)
  • GF Score™: 77/100 with 5 warning signs

No single metric tells the full story. See the FRA:2X7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OrthoPediatrics Business Description

Other Exchanges KIDS:USA
Address 2850 Frontier Drive, Warsaw, IN, USA, 46582
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.
77GF Score

Get the complete analysis for FRA:2X7

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.70
Price
€31.63
GF Value